Aldevron's mRNA Capabilities | Nate Spangler, Ph.D.
Presented by Nate Spangler, Ph.D., Director of Innovation and Strategy. Presented at ASGCT 2020.
With the advent of the COVID-19 pandemic, mRNA is showing promise in supporting breakthrough therapies for the disease. Spangler walks us through Aldevron’s mRNA platform, which offers mRNA in Research Grade to cGMP quality levels to support projects from discovery to clinical development.
To learn more, visit http://www.aldevron.com/mrna
#Aldevron #Biotechnology #ASGCT20